Introduction
It is well known that the menstrual cycle is controlled by the ovarian steroid hormones oestrogen and progesterone which are mainly responsible for proliferation and differentiation of the endometrium. Endometrial cells involved in this cyclic change are of different origin. In addition to epithelial cells (glandular epithelial cells and surface epithelium) and fibroblasts-the latter being transformed to pre-decidual cells in the late secretory phase of the cycle-there are immunocompetent cells including macrophages, T lymphocytes and large granular lymphocytes (LGL). In particular, LGL increase during the luteal phase (Bulmer et al., 1988; King et al., 1989; King and Loke, 1991; Dietl et al., 1992) and abound in this phase of the cycle. Hence, uterine mucosa consists of different cell types, which are regulated distinctly by steroid hormones and paracrine factors. We have focused on the analysis of the hormonal control of these various cell populations. Cell markers of the menstrual cycle were evaluated separately for epithelial glands and stromal cells. In cell culture, epithelial cells and fibroblasts were also separately cultured and assessed. The follicular phase of the cycle which is dominated by oestrogen, was compared with cell culture in the presence of oestrogen. The luteal phase of the cycle, which is characterized by high plasma progesterone concentrations, was compared with cell cultures in the presence of gestagen. Thus, the intention of our study was to gain further knowledge for the treatment of infertility and for hormone replacement therapy. 
Experimental setup
Uterine tissue samples were taken from hysterectomy material obtained directly after surgery. Approval was obtained from the Ethics Committee of the Medical Faculty of the University of Aachen. Uterine tissue was frozen immediately in liquid nitrogen and stored at -20°C until processed for immunohistochemistry. Tissue samples for paraffin-embedding were fixed in neutral buffered 3.7% formalin for 24 h, dehydrated in increasing ethanol concentrations and processed routinely. Different antibodies were used for immunohistochemistry of the marker molecules (Table I) . For cell culture, tissue was minced under a laminar flow into 1-mm 3 fragments and digested by shaking for 1-2 h in 0.125% type I A collagenase (470 units/mg; Sigma, Deisenhofen, Germany) at 37_C in Dulbecco's minimal essential medium (DMEM)/Ham's F12 (ccPro, Neustadt, Germany). Phenol red was omitted from the media, which contained 1% streptomycin, penicillin and fungizone and 10% charcoal-treated steroid hormone-free fetal calf serum (FCS; ccPro).
Further mechanical separation was performed with repeated suction by pipetting. Stromal and epithelial cells were separated by two filtration steps (Figure 1 ) (Classen-Linke et al., 1997) . The cells were seeded at a density of 2-5×10 5 cells/cm 2 on a transparent Biopore membrane with a membrane pore size of 0.4 µm (Millicell CM-filters, 12 mm; Millipore, Eschborn, Germany) coated with Matrigel (Becton Dickinson, Heidelberg, Germany). This was diluted 1:3 with culture medium without any additions in a dual-chambered Millicell system. From a single endometrial specimen, 10-12 inserts could be seeded with the same amount of cells and treated after an adhesion and proliferating phase of 2-4 days with different steroid hormones (Sigma, Deisenhofen, Germany). 17-β-oestradiol was used at a concentration of 10 -8 M, and medroxyprogesterone acetate (MPA; a metabolically stable progestin) at a concentration of 10 -6 M. Both hormones were diluted in ethanol. The anti-oestrogen ICI 182.780 was diluted in dimethylsulphoxide to a final concentration of 10 -6 M. Medium was replaced every 2 days with 0.1 ml in the insert and 0.5 ml in the basal compartment of the 24 Transwell plate (Nunc, Naperville, Illinois, USA). Cultures were usually maintained for 10-14 days, viewed using an inverted microscope and photographed after immunohistochemical staining. For immunohistochemistry, cultures were fixed with neutral buffered 4% formaldehyde for 10 min. Triton X (0.5%) was applied for 5 min to permeate the cell membrane. A streptavidin-biotin secondary antibody system (Zymed, San Francisco, CA, USA), with aminoethylcarbazole as the chromogen, was employed to visualize antigenic sites. Immunohistochemistry was performed in the inserts and in some cases also on Lab-Tek (Nunc) coated with Matrigel. The principle of the experimental procedure for stromal cells and epithelial cells is shown in Figures 2 and 3 .
After 6-8 days in culture without any hormones, 17-β-oestradiol at a concentration of 10 -8 M and MPA at 10 -6 M (single or together) were added to culture medium for 4-7 days, and ICI 182.780 at a concentration of 10 -6 M (with and without oestradiol). Cell RNA was then isolated and oestrogen receptors (OR) and progesterone receptors (PR) were detected by non-radioactive RT-PCR using the DIG dUTP method. The primers used have been described previously (Classen-Linke et al., 1997) .
In parallel with primary cell cultures, the hormonal regulation of endometrial cells in vivo was assessed and endometrial tissue sections (cryostat or paraffin sections) were identified during the menstrual cycle and assessed immunohistochemically. An exact uterine dating was performed (Noyes et al., 1950; Dallenbach-Hellweg and Poulson, 1985) . Serum concentrations of 17-β-oestradiol, progesterone and luteinizing hormone (LH) were measured on the day of hysterectomy.
Immunohistochemical characterization of marker molecules
We have investigated several endometrial cell markers which undergo cyclic changes in their expression pattern during the menstrual cycle, and compared them with the expression pattern of these antigens in separated epithelial and fibroblast cells in cultures containing oestrogen, gestagen and anti-oestrogen. As shown in Table II , there are differences between the follicular and luteal phases, and between epithelial glands and stromal cells.
In the follicular phase, strong proliferation becomes visible using the proliferation marker Ki-67 (Figure 4a ), which stains epithelial and stromal cell nuclei. The proto-oncogene Bcl-2 (Figure 5a ), which prevents apoptosis, is strongly expressed during the follicular phase.
During the mid to late luteal phase, both markers are no longer detectable in glandular epithelium, although still positive in the stromal compartment (Figures 4b and 5b ). OR and PR are strongly expressed in the follicular phase in glandular epithelial and stromal cell nuclei. During the progesterone-dependent mid luteal phase, receptors are downregulated in glandular epithelium of the functionalis and barely detectable at the end of the luteal phase. Within the stromal compartment, OR and PR persist in the luteal phase, although OR become reduced in both intensity and numbers (Table II; Figures 6 and 7) . β 3 integrin, the subunit of the vitronectin receptor, has been proposed as one of three markers of the implantation window (Lessey et al., 1992) . It could be detected with three different antibodies (Table I ) and localized in glandular epithelium from cycle day 20 until the end of the luteal phase (Table II ; Figure 8 ). Stromal cells were positively stained throughout the entire menstrual cycle, with a slight decrease in the luteal phase. Leukaemia inhibitory factor (LIF) is believed to have a role in implantation (Stewart et al., 1992) , being expressed most intensely during the mid to late luteal phase in glandular epithelium but weakly or negatively during the follicular phase (Table II; Figure 9 ). The stromal compartment showed a positive staining throughout the menstrual cycle with some intense staining of single stromal cells in the luteal phase (Figure 9b ).
Connective tissue of the endometrium is composed of many different cells besides fibroblasts. As such tissue contains different forms of immunocompetent cells, we examined it for T lymphocytes, macrophages and large granular lymphocytes (LGL). In the present study, only data on LGL are shown. There was a strong increase of LGL in the mid to late luteal phase, presumably due to proliferation of LGL. This was shown by double immunohistochemistry using the LGL marker CD-56 and the proliferation marker MIB 1 (Figures 10 and 11a ). Further studies with isolated lymphocytes in controlled co-culture are currently under investigation and show promising effects.
Hormonal regulation under in-vitro conditions
The immunohistochemistry of endometrial tissue throughout the menstrual cycle was a prerequisite of the study of cells in culture. To compare results on ex-vivo and in-vitro data, we performed immunohistochemistry on cultured cells. In culture, cell proliferation was proven using immunohistochemical methods to measure Ki-67 antigen detection, and β 3 integrin and LIF could be detected (Table III) . The closest relation to hormonal substitution was obtained by immunohistochemical detection of OR and PR. Oestrogen substitution caused a significant expression of hormone receptors and hormone withdrawal, and MPA addition particularly downregulated the steroid receptors (Table III; Figures 12 and 13) .
Transcription levels in cultured epithelial cells and fibroblasts under different hormone substitutions were analysed using non-radioactive semiquantitative RT-PCR by the DIG dUTP method. Oestrogen substitution caused high levels of mRNA transcripts for OR and PR in fibroblasts and epithelial cells. Gestagen substitution downregulated both receptors in epithelial cells. In fibroblasts, OR and PR were reduced, albeit to a lesser extent with PR ( Figure 14) . To test the action of anti-oestrogens in cell culture, experiments using the supplementation of the pure anti-oestrogen ICI 182.780 in culture medium were performed. As shown in Figure 15 , synthesis of the progesterone receptor was diminished in consequence of its antagonistic effect towards oestrogen, as 17-β-oestradiol is known to induce the synthesis of PR molecules. 
Comparison of marker expression in vivo and in vitro
We have studied the expression of Ki-67, Bcl-2, steroid hormone receptors, LIF and β 3 integrin in human endometrium throughout the menstrual cycle and compared these investigations with results obtained on endometrial stromal and epithelial cells in vitro after various hormone substitutions.
Ki-67 and Bcl-2
Cell proliferation in different phases of the cycle was detected immunohistochemically by the monoclonal antibody MIB 1 against the proliferation marker Ki-67 (Gerdes et al., 1983) . This nuclear antigen occurs in all phases of the cell cycle, besides G 0 and early G 1 . In the follicular phase, under the influence of oestrogens, there is a strong staining of epithelial and stromal cell nuclei. In the early luteal phase, proliferation is diminished in glandular cells and in the mid to late secretory phase there is virtually no more staining, confirming the results of Shiozawa et al. (1996) . However, in the stromal compartment, there are positively stained cell nuclei during the follicular as well as the luteal phase. During the luteal phase, the fraction of proliferating cells is composed of fibroblasts and lymphocytes, as shown by double-immunfluorescent staining.
In epithelial cell and fibroblast cultures, the presence of immunohistochemically proliferating cells was identified, but proliferation rates did not depend significantly on hormone substitution. Other time schedules might be necessary to avoid confluency during investigations of hormonal effects on proliferation in vitro. The proto-oncogene Bcl-2 is a characteristic marker for cells which do not enter apoptosis, and is localized in the nuclear envelope, the endoplasmic reticulum and outer mitochondrial membrane (Krajewski et al., 1993; Kroemer, 1997) . Strong cytoplasmic staining of glandular epithelial cells occurred in the follicular phase, in agreement with data reported by Gompel et al. (1994) , and some staining arose in stroma, i.e. in single cells and especially lymphoid follicles. In the early luteal phase, a decreased percentage of glands were positive, and by the mid to late luteal phase most glands were negative for Bcl-2. In the stroma, positively stained cells have been detected during the luteal phase, and these could in part belong to the fraction of immunocompetent cells (Koh et al., 1995). This expression pattern of Bcl-2 is probably induced by oestrogens in the follicular phase, and downregulated by progesterone in the luteal phase.
The Bcl-2 proto-oncogene could not be detected immunohistochemically after 14 days, neither under oestrogen nor MPA substitution in epithelial cell and fibroblast cultures. This indicates a more complex control of this protein, and further investigations are thus necessary, especially to evaluate the interactions between different cell types and the influence of various cytokines such as tumour necrosis factor-α (TNF-α) or interferon-γ (IFN-γ), which are believed to be involved in apoptosis.
β 3 integrin and LIF Expression of β 3 integrin, which is the subunit of the vitronectin receptor, and LIF were investigated in relation to the state of receptivity of the endometrium before implantation. β 3 integrin was postulated by Lessey et al. (1992) as one of three markers of the implantation window. Low staining of glandular epithelium could be discerned in the early proliferative phase, while in the late proliferative phase, the reaction was almost negative. By the early secretory phase, reactions were completely negative in the glands. After day 20, >50% of the glands were β 3 integrin-positive in the mid luteal phase, as shown using three different antibodies. By the late luteal phase, 40% of the glands were still stained. In the stromal compartment, a homogeneous β 3 integrin staining could be observed, which decreased in intensity during the mid to late luteal phase. Figure 14 . Detection of mRNA transcripts of oestrogen receptor (ER) and progesterone receptor (PR) of cultured epithelial and fibroblast cells by non-radioactive RT-PCR. After 6 days without hormones, cells were cultured in the presence of oestrogen (E 2 ; 10 -8 M), gestagen (MPA; 10 -6 M), or both together for 4 days. As an internal control, the subunit I of cytochrome-c oxidase (1A) which is not regulated by steroid hormones was used. In fibroblast cells, the oestrogen and progesterone receptors were clearly detectable after oestradiol substitution, in addition to MPA substitution. Substitution of MPA without oestradiol reduced mRNA transcripts for the steroid hormone receptors, with PR being reduced to a lesser extent. In epithelial cells, steroid hormone receptors were clearly detectable under oestrogen substitution. PR is reduced under MPA + oestradiol substitution. With MPA, only the steroid hormone receptors are both downregulated. As an internal control, the subunit I of cytochrome-c oxidase (1A) was used, since it is not regulated by steroid hormones. Note how PR is strongly downregulated by the action of the pure anti-oestrogen ICI 182.780.
In cell culture, β 3 integrin could be detected in epithelial cells as well as in fibroblasts. The intensity of the reaction was stronger under MPA -substitution, although its fine regulation might depend not only on steroid hormones but also on interactions between cells. LIF RNA and protein have been identified in human endometrium (Charnock-Jones et al., 1994; Vogiagis et al., 1996) . Knock-out mice without an active LIF gene are infertile (Stewart et al., 1992) . During the mid to late luteal phase, LIF immunoreactivity is significantly enhanced in the glandular epithelial cells, which may underline the important role of this cytokine in human receptivity.
In cell culture, LIF was detected immunohistochemically in epithelial cells only, and it did not depend significantly on hormone substitution. This was in agreement with results reported by Arici et al. (1995) and Laird et al. (1997) . The regulation of LIF might be influenced both by steroid hormones, and by several cytokines such as TNF-α, epidermal growth factor (EGF) and transforming growth factor-β (TGF-β) (Arici et al., 1995) .
Oestrogen and progesterone receptors
Several investigations into the biochemical and immunohistochemical detection of OR and PR have been carried out in human endometrium (Press et al., 1984; Bergeron et al., 1988; Lessey et al., 1988; Bouchard et al., 1991; Snijders et al., 1992; Bergqvist et al., 1993; Coppens et al., 1993; Ravn et al., 1994; Salat-Baroux et al., 1994; Shiozawa et al., 1996) . The endometrium is a target for steroid hormones, expressing steroid hormone receptors strongly from the follicular phase to the end of the early luteal phase in glandular epithelial and in stromal cell nuclei. In the mid luteal phase, OR and PR are strongly reduced in the glandular epithelial cells of the functionalis to 40% of their original level. In the late luteal phase, receptor staining is absent. In the basalis, many of the cell nuclei remain positively stained during the mid to late luteal phase. PR concentrations in stroma do not change significantly during the menstrual cycle, whereas OR diminish in intensity in the functionalis during the luteal phase.
PR increase in concentration in response to synthesis invoked by oestrogens, and this increase is preceded by an oestrogen-mediated increase in PR mRNA levels (Clarke and Sutherland, 1990; Aronica and Katzenellenbogen, 1991) . Consequently, we concentrated on the influence of hormones inducing or downregulating their own receptors. Oestrogen induces both its own receptor (Jensen and De Sombre, 1972) and the PR (Milgrom and Baulieu, 1970) . Progesterone also downregulates its own receptor (Milgrom et al., 1973; Read et al., 1988) . However, progesterone antagonizes the oestrogen action by inhibiting the synthesis of OR (Tseng and Gurpide, 1975; Tseng, 1979) . In vitro, OR and PR are in fact induced by oestrogen action and are downregulated by MPA. The functional properties of OR could be proved by PR expression.
Anti-oestrogens act by competitive binding to the OR, blocking oestrogen action and thereby also affecting the PR. This could be demonstrated by the use of the pure anti-oestrogen ICI 182.780 (Wakeling and Bowler, 1988; Wakeling et al., 1991) , which has no partial oestrogenic activity, as does tamoxifen. Recently, Widra et al. (1997) studied β 3 expression in an Ishikawa-CH cell line and postulated that oestradiol influences the expression of α v β 3 because its addition to the medium resulted in a loss of staining. Hochner-Celnikier et al. (1997) performed proliferation studies with OR-positive (Ishikawa) and OR-negative (HEC-1A) cell lines by adding oestradiol or tamoxifen to the culture media.
It remains questionable whether the effects obtained with cell lines of either well-characterized or poorly differentiated endometrial adenocarcinoma cells (Ishikawa resp. HEC-1A) are comparable with such a primary endometrial cell culture as described here. Our cell line actually expresses OR and PR, as in physiological conditions.
Our results prove that an endometrial primary cell culture system can serve as a suitable screening system for steroid hormone effects and their specific antagonists, particularly with regard to steroid hormone receptor expression. Comparisons with results in vivo permit a strict correlation to be made with results obtained in vitro. In our view, this endometrial cell culture system represents an excellent tool for the analysis and preclinical screening of hormones and hormone antagonists which are being developed for therapeutic use.
